全文获取类型
收费全文 | 1309919篇 |
免费 | 86835篇 |
国内免费 | 2377篇 |
专业分类
耳鼻咽喉 | 17515篇 |
儿科学 | 40540篇 |
妇产科学 | 32996篇 |
基础医学 | 183021篇 |
口腔科学 | 33860篇 |
临床医学 | 119277篇 |
内科学 | 253022篇 |
皮肤病学 | 27670篇 |
神经病学 | 105044篇 |
特种医学 | 52866篇 |
外国民族医学 | 214篇 |
外科学 | 200147篇 |
综合类 | 24295篇 |
现状与发展 | 3篇 |
一般理论 | 448篇 |
预防医学 | 91453篇 |
眼科学 | 29910篇 |
药学 | 101745篇 |
8篇 | |
中国医学 | 3131篇 |
肿瘤学 | 81966篇 |
出版年
2021年 | 12999篇 |
2019年 | 12864篇 |
2018年 | 17509篇 |
2017年 | 13417篇 |
2016年 | 15003篇 |
2015年 | 17041篇 |
2014年 | 23579篇 |
2013年 | 33481篇 |
2012年 | 47764篇 |
2011年 | 50195篇 |
2010年 | 29040篇 |
2009年 | 27100篇 |
2008年 | 45764篇 |
2007年 | 48499篇 |
2006年 | 48622篇 |
2005年 | 46816篇 |
2004年 | 44669篇 |
2003年 | 42326篇 |
2002年 | 40632篇 |
2001年 | 61948篇 |
2000年 | 62913篇 |
1999年 | 52960篇 |
1998年 | 15212篇 |
1997年 | 13236篇 |
1996年 | 12934篇 |
1995年 | 12093篇 |
1994年 | 10901篇 |
1993年 | 10360篇 |
1992年 | 38795篇 |
1991年 | 37197篇 |
1990年 | 36550篇 |
1989年 | 35044篇 |
1988年 | 31564篇 |
1987年 | 30642篇 |
1986年 | 28886篇 |
1985年 | 27138篇 |
1984年 | 20114篇 |
1983年 | 16917篇 |
1982年 | 9881篇 |
1979年 | 17511篇 |
1978年 | 11949篇 |
1977年 | 10691篇 |
1976年 | 9273篇 |
1975年 | 10406篇 |
1974年 | 11980篇 |
1973年 | 11552篇 |
1972年 | 10947篇 |
1971年 | 10275篇 |
1970年 | 9375篇 |
1969年 | 9028篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
J Müller-Quernheim K I Gaede E Fireman G Zissel 《The European respiratory journal》2006,27(6):1190-1195
An increase in chronic beryllium disease (CBD) has been suggested due to higher industrial use of beryllium alloys. Since occupational CBD is a perfect phenocopy of sarcoidosis, it might be misdiagnosed as sarcoidosis. In the current it was hypothesised that CBD exists in cohorts of sarcoidosis patients. In a prospective case study, sarcoidosis patients were evaluated for potential beryllium exposure. In those patients in whom beryllium exposure was confirmed and beryllium hypersensitivity demonstrated, the diagnosis of sarcoidosis was rejected and corrected to CBD. In 84 patients seen for re-evaluation or making a diagnosis of sarcoidosis, beryllium exposure was recognised and a diagnosis of CBD was made in 34 out of 84 patients. The time lag between clinical diagnosis of sarcoidosis and the final diagnosis of CBD ranged 0-18 yrs (median 3 yrs) and the mean (range) age at time of diagnosis of CBD was 43.9(25-80) yrs. Beryllium-contaminated workplaces causing disease encompassed a wide spectrum of industries and technical trades in which beryllium-exposure is generally not perceived as a health hazard. In conclusion, chronic beryllium disease still belongs to the spectrum of differential diagnoses of granulomatous disorders. 相似文献
42.
灾难的时代错误:灾害医学的过去、现在和将来(一) 总被引:1,自引:0,他引:1
灾难,特别是地震、火山、洪水以及与战争有关的事件如饥饿和流行性传染病,是人类有记录的经历的一部分。从意大利庞贝的火山爆发,到约翰斯顿的洪水、第二次世界大战和黑色瘟疫,到西班牙流感,都发生了灾难,这不会被传说和历史书籍长期忘却。不过,在20世纪中叶以前,那些灾难的发生相对较少,且相距时间较长。从20世纪中叶以来,灾难的本质发生了变化。从恐怖分子使用“新技术”,到与气候有关的导致亿万美元经济损失的事件,表明这个世界正在发生变化。仅仅在最近的50~60年间,造成多种多样的伤亡事件,其危险性和频率的增加引人注目,并且注定要在接… 相似文献
43.
R E Dales A Mehdizadeh S D Aaron K L Vandemheen J Clinch 《The European respiratory journal》2006,28(2):319-322
The aim of the present study was to explore differences in the clinical expression, clinical diagnoses and management of airway diseases in a primary-care setting. Patients aged >or=35 yrs who had ever smoked were enrolled when they presented for any reason to one of eight rural primary-care practices. Respiratory symptom questionnaires and spirometry were administered. In total, 1,034 patients had acceptable and reproducible spirometry, of whom 550 (53%) were males and 484 (47%) were females. Males smoked more than females (41.2 versus 29.2 pack-yrs) respectively, and were more likely to have a pre-bronchodilator forced expiratory volume in one second/forced vital capacity <0.70 at 22.4 versus 11.8%, respectively. However, more females than males reported breathlessness (51.0 versus 42.8%, respectively), a prior diagnosis compatible with airflow obstruction and taking respiratory medications (23.4 versus 14.9%, respectively). In conclusion, the current results suggest that females are more likely than males to report breathlessness and be prescribed respiratory medications independent of differences in the severity of airflow obstruction. 相似文献
44.
M Engelhardt P Bast N Jeblink W Lauer A Popovic H Eufinger M Scholz A Christmann A Harders K Radermacher K Schmieder 《Minimally invasive neurosurgery》2006,49(2):98-103
This study was performed to evaluate the surgical strategy in patients with calvarial tumours, in order to design and modify a robot-assisted trepanation system. A total of 75 patients underwent craniectomy for the treatment of calvarial tumours during the 10-year period from 1993 to 2002. The patients' complaints, the size, location and histology of the tumour, and the various cranioplasty techniques used were analysed retrospectively. In a second procedure several craniectomies at typical locations according to the study's results were performed in a laboratory setting using a hexapod robotic tool, constructed at the Helmholtz-Institute, RWTH Aachen University, and plastic model heads. The workflow was documented and the reproducibility and the accuracy of the procedure were registered. A total of 83 surgical procedures were performed on 75 patients. The majority (87 %) of lesions treated surgically were located in the frontal, temporal and anterior parts of the parietal region. Histological examination revealed benign lesions in 66 % of the patients and dural involvement in 46 %. According to these results craniectomies were performed using the robotic system. Mean positioning accuracy of the robotic system while milling was 0.24 mm, with a standard deviation of 0.04 mm, and maximum error under 1 mm. Craniectomies leaving a 1-mm layer of the tabula interna intact to ensure a healthy dura were performed in several regions successfully. The majority of calvarial tumours, requiring surgical treatment in our patients, were located in cosmetically relevant areas in which drilling can be carried out with the robotic trepanation system. Consequently, the surgical approach had to be planned carefully in order to achieve a good cosmetic outcome. 相似文献
45.
Allison J. Cowin PhD ; Nicholas Hatzirodos BSc ; Justin Rigden PhD ; Robert Fitridge FRACS ; David A. Belford PhD 《Wound repair and regeneration》2006,14(4):421-426
High levels of tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine, are present in the wound fluid of chronic nonhealing wounds. This leads to increased inflammation, cytokine expression, and ultimately results in impaired wound healing and tissue destruction. Etanercept is a recombinant fusion protein that consists of the soluble TNF receptor (p75) linked to the Fc portion of human IgG1. It is an effective inhibitor of TNF-alpha and has been shown to provide rapid and sustained improvement in rheumatoid arthritis by acting as a soluble receptor binding TNF-alpha and preventing its proinflammatory activities. Therefore, the aim of this study was to determine whether Etanercept could inhibit TNF-alpha activity in chronic wound fluid. Wound fluid was collected from the venous leg ulcers of 16 different patients. The effect of Etanercept on TNF-alpha activity was evaluated using both a TNF-alpha bioassay and an enzyme-linked immunoassay. Etanercept was found to reduce the cytotoxic effect of chronic wound fluid on L929 fibroblasts by approximately 30% and neutralized TNF-alpha binding in the enzyme-linked immunoassay by up to 80%. Direct application of Etanercept to chronic wounds may therefore reduce the inflammatory activity of TNF-alpha, which could reduce the chronicity of venous leg ulcers and thus aid in the healing of these wounds. 相似文献
46.
47.
48.
49.
Dear Sir In the recently published Task force report, under section Fibrinolyticregimens, the authors recommend not to re-administerstreptokinase for at least 10 years. The reference supportingthis statement is Ref. 51. After evaluating this paper and lookinginto the literature my comments 相似文献
50.
Four clinical trials of porcine islet transplantation have been reported, and there are verbal reports that clinical trials on much larger scales are continuing in centers in China and Russia. The four reported trials are briefly reviewed and, in the light of the present status of experimental islet xenotransplantation, consideration is given to whether such trials are currently justified. The Ethics Committee of the International Xenotransplantation Association has (1) emphasized the need for encouraging studies in non-human primates before clinical trials should be undertaken, (2) mandatory monitoring for the transfer of porcine microorganisms, and (3) careful regulation and oversight by recognized bodies. Other aspects of the topic, such as the need for informed consent, are briefly discussed. We conclude that, at the present time, more data documenting convincing efficacy, focused on clinically applicable immunosuppressive regimens, are needed to justify the initiation of closely monitored clinical trials. A clinical trial may then be justified even though the potential risk to the patients, and possibly for society, will not be zero. 相似文献